Stay updated on Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The Study Record Dates section now shows Revision: v3.6.5, indicating a new revision of the page entry. No study details, enrollment information, or eligibility criteria appear to be altered.
    Difference
    0.1%
    Check dated 2026-08-10T16:27:01.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4, signaling a new version of the page. This indicates a maintenance update without altering the study information.
    Difference
    0.1%
    Check dated 2026-07-27T06:24:21.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The study record includes metadata updates: a new last update date, revised estimated study completion dates, and removal of the old registry identifier, with other historical dates added. These changes update timeline and registry references but do not modify treatment, eligibility, or participating locations.
    Difference
    0.4%
    Check dated 2026-07-12T20:25:49.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.2 to v3.6.3, indicating a minor platform update. This change does not affect study content, eligibility, or outcomes.
    Difference
    0.1%
    Check dated 2026-07-05T12:43:59.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.2, replacing the previous v3.6.0. This signals a minor update to the page version rather than a change to the study content.
    Difference
    0.1%
    Check dated 2026-06-28T04:59:53.000Z thumbnail image
  9. Check
    75 days ago
    Change Detected
    Summary
    Recruitment status is updated to indicate enrollment is closed, with the addition of guidance sections for reading the study record and joining a study; the page also shows an updated Intervention/Treatment header and a new revision note (Revision: v3.6.0).
    Difference
    0.4%
    Check dated 2026-06-13T17:33:24.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial page.